Home › Compare › IDRA vs VICI

IDRA vs VICI: Dividend Comparison 2026

IDRA yields 470.59% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IDRA wins by $38544.15M in total portfolio value
10 years
IDRA
IDRA
● Live price
470.59%
Share price
$0.43
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38545.12M
Annual income
$27,182,357,871.92
Full IDRA calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — IDRA vs VICI

📍 IDRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIDRAVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IDRA + VICI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IDRA pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IDRA
Annual income on $10K today (after 15% tax)
$40,000.00/yr
After 10yr DRIP, annual income (after tax)
$23,105,004,191.13/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, IDRA beats the other by $23,104,487,921.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IDRA + VICI for your $10,000?

IDRA: 50%VICI: 50%
100% VICI50/50100% IDRA
Portfolio after 10yr
$19273.04M
Annual income
$13,591,482,624.02/yr
Blended yield
70.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

IDRA
Analyst Ratings
5
Buy
4
Hold
Consensus: Buy
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IDRA buys
0
VICI buys
0
No recent congressional trades found for IDRA or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIDRAVICI
Forward yield470.59% ✓6.52%
Annual dividend / share$2.00 ✓$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3% ✓
Portfolio after 10y$38545.12M ✓$966.2K
Annual income after 10y$27,182,357,871.92 ✓$607,376.13
Total dividends collected$37542.88M ✓$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: IDRA vs VICI ($10,000, DRIP)

YearIDRA PortfolioIDRA Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$57,759$47,058.82$11,361$941.49+$46.4K → IDRA
2$315,826$254,024.51$13,320$1,481.32+$302.5K → IDRA
3$1,636,076$1,298,141.44$16,284$2,405.01+$1.62M → IDRA
4$8,035,425$6,284,824.27$21,040$4,071.78+$8.01M → IDRA
5$37,445,846$28,847,941.19$29,209$7,285.49+$37.42M → IDRA
6$165,706,448$125,639,392.36$44,443$14,006.51+$165.66M → IDRA
7$696,916,266$519,610,366.98$75,822$29,512.55+$696.84M → IDRA
8$2,788,074,169$2,042,373,764.24$148,733$69,726.75+$2787.93M → IDRA
9$10,619,401,952$7,636,162,591.12$344,394$189,413.75+$10619.06M → IDRA
10$38,545,117,961$27,182,357,871.92$966,234$607,376.13+$38544.15M → IDRA

IDRA vs VICI: Complete Analysis 2026

IDRA — Stock

Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.

Full IDRA Calculator →

VICI — REIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this IDRA vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IDRA vs SCHDIDRA vs JEPIIDRA vs OIDRA vs KOIDRA vs MAINIDRA vs NNNIDRA vs EPRTIDRA vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.